Quantitative characterization of the corticospinal tract at 3T.
Daniel S. Reich(National Institutes of Health), Susumu Mori(Johns Hopkins University), Craig Jones(Johns Hopkins University), Seth A. Smith(Vanderbilt University), Peter C. van Zijl, Peter A. Calabresi(Johns Hopkins University), Kathleen M. Zackowski(Kennedy Krieger Institute)
PubMed
March 29, 2007
Cited by 105
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
|The Lancet|2011|743
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624